Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

  title={Can peripheral leukocytes be used as Alzheimer's disease biomarkers?},
  author={Kavon Rezai-zadeh and David Gate and Christine A Szekely and Terrence C. Town},
  journal={Expert review of neurotherapeutics},
  volume={9 11},
Alzheimer's disease (AD) is the leading cause of dementia in elderly populations throughout the world and its incidence is on the rise. Current clinical diagnosis of AD requires intensive examination that includes neuropsychological testing and costly brain imaging techniques, and a definitive diagnosis can only be made upon postmortem neuropathological examination. Additionally, antemortem clinical AD diagnosis is typically administered following onset of cognitive and behavioral symptoms. As… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…